348 related articles for article (PubMed ID: 15172630)
81. LDL-apheresis: indications and clinical experience in a tertiary cardiac centre.
Archontakis S; Pottle A; Hakim N; Ilsley C; Barbir M
Int J Clin Pract; 2007 Nov; 61(11):1834-42. PubMed ID: 17935547
[TBL] [Abstract][Full Text] [Related]
82. Extracorporeal LDL cholesterol elimination (25 years of experience in CZ).
Blaha M; Zadak Z; Blaha V; Andrys C; Havel E; Vyroubal P; Blazek M; Filip S; Lanska M; Maly J
Atheroscler Suppl; 2009 Dec; 10(5):17-20. PubMed ID: 20129368
[TBL] [Abstract][Full Text] [Related]
83. [A case with homozygote familial hypercholesterolemia treated with LDL apheresis and coronary bypass in adolescence period].
Altinel E; Cetinkaya S; Kara C; Orün UA; Aydin H; Kutsal A
Anadolu Kardiyol Derg; 2008 Jun; 8(3):231-2. PubMed ID: 18524734
[No Abstract] [Full Text] [Related]
84. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.
Morimoto S; Yano Y; Maki K; Sawada K; Iwasaka T
Am J Nephrol; 2007; 27(6):643-8. PubMed ID: 17878713
[TBL] [Abstract][Full Text] [Related]
85. LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2alpha.
Oguogho A; Ferlitsch A; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 2000 Apr; 62(4):209-16. PubMed ID: 10882184
[TBL] [Abstract][Full Text] [Related]
86. Long-Term Follow-Up of a Homozygous Familial Hypercholesterolemic Patient Receiving Regular Double Filtration Plasmapheresis - Case Report and Literature Review.
Tsai JL; Wu MJ; Shu KH; Tsai SF
Blood Purif; 2016; 41(4):264-9. PubMed ID: 26731699
[TBL] [Abstract][Full Text] [Related]
87. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis.
Bosch T
Transfus Apher Sci; 2004 Oct; 31(2):83-8. PubMed ID: 15501411
[TBL] [Abstract][Full Text] [Related]
88. Acute and chronic effects of therapeutic apheresis.
Ramunni A; Petrarulo F; Grasso C; Papagni S; Brescia P
Atheroscler Suppl; 2013 Jan; 14(1):83-7. PubMed ID: 23357147
[TBL] [Abstract][Full Text] [Related]
89. Effect of different LDL-apheresis methods on parameters involved in atherosclerosis.
Hershcovici T; Schechner V; Orlin J; Harell D; Beigel Y
J Clin Apher; 2004; 19(2):90-7. PubMed ID: 15274202
[TBL] [Abstract][Full Text] [Related]
90. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
Horstkotte D; Mellwig KP
Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
[TBL] [Abstract][Full Text] [Related]
91. Pulsed flow cascade filtration. Long-term experience in low density lipoprotein and lipoprotein a removal.
Legallais C; Moriniére P; Fournier A; Jaffrin MY
ASAIO J; 1996; 42(5):M463-7. PubMed ID: 8944924
[TBL] [Abstract][Full Text] [Related]
92. Long-term experience with the HELP system for treatment of severe familial hypercholesterolemia.
Eisenhauer T; Schuff-Werner P; Armstrong VW; Talartschik J; Scheler F; Seidel D
ASAIO Trans; 1987; 33(3):395-7. PubMed ID: 3675971
[No Abstract] [Full Text] [Related]
93. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
[TBL] [Abstract][Full Text] [Related]
94. Protein adsorption during LDL-apheresis: proteomic analysis.
Dihazi H; Koziolek MJ; Söllner T; Kahler E; Klingel R; Neuhoff R; Strutz F; Mueller GA
Nephrol Dial Transplant; 2008 Sep; 23(9):2925-35. PubMed ID: 18398017
[TBL] [Abstract][Full Text] [Related]
95. Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease.
Pusl T; Broedl UC; Parhofer KG; Otto C
Clin Hemorheol Microcirc; 2009; 41(2):137-42. PubMed ID: 19252236
[TBL] [Abstract][Full Text] [Related]
96. Selectins and monocyte chemotactic peptide as the markers of atherosclerosis activity.
Bláha M; Krejsek J; Bláha V; Andrýs J; Vokurková D; Malý J; Blazek M; Skorepová M
Physiol Res; 2004; 53(3):273-8. PubMed ID: 15209534
[TBL] [Abstract][Full Text] [Related]
97. Differential effects of lipoprotein apheresis by lipidfiltration or dextran sulfate adsorption on lipidomic profile.
Gräßler J; Kopprasch S; Passauer J; Fischer S; Schuhmann K; Bergmann S; Siegert G; Shevchenko A; Bornstein SR; Julius U
Atheroscler Suppl; 2013 Jan; 14(1):151-5. PubMed ID: 23357157
[TBL] [Abstract][Full Text] [Related]
98. LDL-apheresis: results of longterm treatment and vascular outcome.
Keller C
Atherosclerosis; 1991 Jan; 86(1):1-8. PubMed ID: 2064631
[TBL] [Abstract][Full Text] [Related]
99. The decrease of mean platelet volume after extracorporeal LDL-cholesterol elimination.
Blaha M; Kostal M; Lanska M; Blaha V; Foralova I; Filip S; Kubisova M; Maly J
Atheroscler Suppl; 2013 Jan; 14(1):77-81. PubMed ID: 23357146
[TBL] [Abstract][Full Text] [Related]
100. Regression of atherosclerosis in patients with familial hypercholesterolaemia under LDL-apheresis.
Borberg H; Gaczkowski A; Hombach V; Oette K; Stoffel W
Prog Clin Biol Res; 1988; 255():317-26. PubMed ID: 3340643
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
